Viridium Pacific Group (CVE:VIR) Shares Up 5.6% – Still a Buy?

Viridium Pacific Group Ltd (CVE:VIRGet Free Report)’s stock price rose 5.6% on Wednesday . The company traded as high as C$0.41 and last traded at C$0.38. 26,500 shares traded hands during trading, a decline of 71% from the average daily volume of 92,632 shares. The stock had previously closed at C$0.36.

Viridium Pacific Group Stock Performance

The firm’s fifty day simple moving average is C$0.38 and its 200-day simple moving average is C$0.38. The stock has a market cap of C$37.52 million and a P/E ratio of -2.97.

About Viridium Pacific Group

(Get Free Report)

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Further Reading

Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.